Medicine Inspection Device Database Scope Control

The patent segments the inspection database into multiple categorized groups (e.g., same generic name medicines, same manufacturer medicines, medicines with similar indications) rather than treating it as a single undifferentiated whole. This segmentation allows the system to perform similarity determination on restricted subsets of medicines rather than the entire database, reducing processing load while maintaining detection completeness for relevant medicines.

The patent applies different reference scopes to different inspection scenarios. Instead of using a uniform reference scope for all similarity determinations, the system dynamically adjusts the reference scope based on the specific medicine being inspected and the inspection context, thereby optimizing the balance between detection completeness and processing efficiency for each case.

The patent divides the large inspection database into multiple smaller categorized subsets (such as medicines with the same generic name, same manufacturer, or similar therapeutic indications). By performing similarity determination on these segmented subsets rather than the entire database, the system maintains accurate comparison within relevant categories while significantly reducing overall processing time.

The patent applies partial action by selectively determining similarity only for medicines within specific categories rather than performing exhaustive comparison with all registered medicines. This partial similarity determination focuses computational resources on the most relevant comparisons, achieving sufficient accuracy for safety purposes without the time cost of complete database scanning.

The patent segments the similarity determination process into multiple targeted comparisons against categorized medicine groups rather than a single exhaustive comparison against the entire database. This segmentation enables the system to maintain comprehensive safety checking within relevant categories while improving inspection throughput by processing smaller, focused datasets in parallel or sequence.

The patent implements partial similarity determination by limiting comparisons to medically relevant categories (such as same generic name or same therapeutic class) rather than performing exhaustive comparisons with all registered medicines. This approach achieves sufficient comprehensiveness for patient safety while significantly improving inspection efficiency by reducing the total number of comparisons required.